Filed: 8/13/2026ACC: 0001172661-26-003381
📋 What this filing means
AIHC CAPITAL MANAGEMENT LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $104.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$104.24M
Total AUM (reported)
7.04M
Total Shares
Allocation by class
COM$98.63M94.6%
SPONSORED ADS$5.61M5.4%
Portfolio Concentration
Top 3$103.85M99.6%
4–10$398.9K0.4%
Top 3 weight
99.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.04M
Sole
Full voting authority
7.04M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
REVOLUTION MEDICINES INC
SOLEShares303.13K
TypeSH
Market value$56.77M
54.46%
Sole
303.13K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares3.83M
TypeSH
Market value$41.46M
39.77%
Sole
3.83M
Shared
0.00
None
0.00
NOVABRIDGE BIOSCIENCES
SOLEShares2.88M
TypeSH
Market value$5.61M
5.38%
Sole
2.88M
Shared
0.00
None
0.00
KORRO BIO INC
SOLEShares30.27K
TypeSH
Market value$398.9K
0.38%
Sole
30.27K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 303.13K | SH | $56.77M 54.46% | 303.13K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 3.83M | SH | $41.46M 39.77% | 3.83M | 0.00 | 0.00 |
NOVABRIDGE BIOSCIENCESSOLE | SPONSORED ADS | 2.88M | SH | $5.61M 5.38% | 2.88M | 0.00 | 0.00 |
KORRO BIO INCSOLE | COM | 30.27K | SH | $398.9K 0.38% | 30.27K | 0.00 | 0.00 |